NCT04049448Phase 2Completed

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Study sponsor: Abivax S.A. · ABVX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2023-01-23Actual
Enrollment · participants40Actual
Source updated2025-11-17Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date

Recorded edit
− Previous value

2021-04-30

+ Updated value

2023-01-23

Check registry source